v3.26.1
CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($)
$ in Thousands
Mar. 31, 2026
Dec. 31, 2025
Current assets:    
Cash and cash equivalents $ 4,791,676 $ 4,547,530
Accounts receivable, net 938,019 865,080
Inventories, net 681,590 608,227
Prepaid expenses and other current assets 189,995 212,752
Total current assets 6,601,280 6,233,589
Property, plant and equipment, net 1,640,918 1,641,678
Operating lease right-of-use assets 145,497 148,184
Intangible assets, net 61,681 62,704
Other non-current assets 104,243 102,418
Total non-current assets 1,952,339 1,954,984
Total assets 8,553,619 8,188,573
Current liabilities:    
Accounts payable 423,546 479,035
Accrued expenses and other payables 1,079,283 1,109,120
Tax payable 63,522 41,625
Operating lease liabilities, current portion 20,584 20,698
Research and development cost share liability, current portion 35,700 64,345
Sale of future royalty liability, current portion 72,735 56,714
Short-term debt 116,140 57,293
Total current liabilities 1,811,510 1,828,830
Non-current liabilities:    
Long-term debt 962,515 961,913
Sale of future royalty liability, non-current portion 831,664 850,242
Operating lease liabilities, non-current portion 49,670 52,940
Deferred tax liabilities 55,866 53,209
Other long-term liabilities 81,952 80,245
Total non-current liabilities 1,981,667 1,998,549
Total liabilities 3,793,177 3,827,379
Commitments and contingencies
Shareholders’ equity:    
Number Of Authorized Shares, Not Disclosed true  
Ordinary shares, $0.0001 par value per share; 1,540,975,898 and 1,540,975,898 shares issued and 1,444,479,378 and 1,441,075,618 shares outstanding as of March 31, 2026 and December 31, 2025, respectively $ 144 144
Additional paid-in capital 12,906,326 12,759,137
Accumulated other comprehensive loss (53,482) (78,184)
Accumulated deficit (8,092,546) (8,319,903)
Total shareholders’ equity 4,760,442 4,361,194
Total liabilities and shareholders’ equity $ 8,553,619 $ 8,188,573